QY-101

N/A

Report date: 2023/03/10 20:00:33
NME

Base Information

Drug NameQY-101
Drug Alias NameQY-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesE-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesE-nitiate Biopharmaceuticals (Hangzhou) Co LtdJoincare Pharmaceutical Group Industry Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A